Additionally, we also aimed to assess the relationship of TAng with AD-ILD+ clinical manifestations and endothelial dysfunction-related biomarkers at the cellular (EPC, CE) and molecular (VEGF mRNA expression and VEGF protein) level. The gene discussed is VEGFA; the disease is interstitial lung disease.